Other transcription factors of lipid metabolism that are altered in the setting of NAFLD include the constitutive androstane receptor (CAR), liver X receptor (LXR), Cyclic AMP-responsive element-binding protein H (CREBH), Farnesoid X receptor (FXR), signal transducer and activator of transcription 5 (STAT5), and CCAAT/enhancer binding protein alpha (C/EBPα) (Table 1). Here, NR1I3 is linked to metabolic dysfunction-associated steatotic liver disease.